|Wednesday 29 April 2015, Athenaeum Intercontinental, Athens|
|Save the date: A must attend summit, for all decision-makers, experts and institutions in healthcare and pharma industries|
10 International speakers, Health and Development ministers, members of Greek government and the Greek Parliament, industry representatives, experts and academics debate on the reshaping of health policies in the context of the current economic crisis.
Representatives from World Health Organization, OECD, World Bank and European Commission discuss future challenges in healthcare.
Healthcare opinion leaders and members debate on health policies, seeking a new balance of efficiency, effectiveness and quality.
Pharma Industry experts discuss access to therapies, sustainable financing of healthcare system, pharma innovation and excellence, as well as the sector’s contribution to the economy.
Members of the academic society present and discuss models and proposals for an effective, cost-efficient, and accessible healthcare system.
This conference features world-class international and local speakers, expert panel discussions, brainstorming sessions and international case studies and will explore best practices through in depth assessment of the present status as well as assessing next steps towards healthy economic growth of healthcare and pharma industries.
- Panagiotis Kouroumplis, Minister of Health
- George Stathakis, Minister of Development
- Andreas Xanthos, Alternate Minister of Health
- Agis Tsouros, M.D., Ph.D., FFPH Director, Policy and Governance for Health and Well-being, WHO
- Dimitris Avramopoulos, Commissioner, Migration and Home Affairs
- Richard Bergstrom, EFPIA General Director
- Gaetan Lafortune, Researcher, Health Services OECD
- Armin Fidler, Lead Adviser, Policy and Strategy, World Bank
- Andrezj Rys, Director for Health Systems and Products, European Commission
- Monique Goyens, President of BEUC (European consumers’ federation)
- Elias Mosialos, Brian Abel-Smith Professor of Health Policy at the Department of Social Policy at the London School of Economics and Political Science (LSE), Director of LSE Health
- Fabio Pammoli, Professor of Economics and Management at IMT, Lucca, Italy
- Panos Kanavos, Deputy Director at LSE Health, London School of Economics
- Konstantinos Frouzis, President of SFEE
- Theodoros Tryfon, President of PEF
- Aaron Reeves, Researcher, Quantitative Sociology, Oxford University
- Roberto Greco, PhRMA Innovation Forum President, CEO GSK Greece
- Michel Goldman, MD, PhD, Immunology Professor, Universite Libre de Βruxelles, Erasmus European Business and Innovation Center, former Executive Director of the Innovative Medicines Initiative Joint Undertaking (IMI)
- Spyros Kokkinakis, Secretary General, Ministry of Health